| dc.contributor.author | Bay, Sema Buyukkapu | |
| dc.contributor.author | Kebudi, Rejin | |
| dc.date.accessioned | 2021-03-03T21:19:26Z | |
| dc.date.available | 2021-03-03T21:19:26Z | |
| dc.date.issued | 2015 | |
| dc.identifier.citation | Kebudi R., Bay S. B. , "Treatment of Hodgkin's lymphoma in children", TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, cilt.30, sa.1, ss.34-44, 2015 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_5e94aa3c-aaeb-485b-968e-abd761d0afba | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/66123 | |
| dc.identifier.uri | https://doi.org/10.5505/tjoncol.2015.1033 | |
| dc.description.abstract | With the advances in current diagnostics and treatment modalities the survival in children with Hodgkin's lymphoma have significantly increased. The aim of the treatment nowadays is administering the most effective and least toxic treatment. This has leaded to "risk adapted, response and gender modified" treatments. In this review, the treatment modalities and results used in Hodgkin's lymphoma in children within decades have been assessed. | |
| dc.language.iso | eng | |
| dc.subject | Onkoloji | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | ONKOLOJİ | |
| dc.title | Treatment of Hodgkin's lymphoma in children | |
| dc.type | Makale | |
| dc.relation.journal | TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY | |
| dc.contributor.department | İstanbul Üniversitesi , , | |
| dc.identifier.volume | 30 | |
| dc.identifier.issue | 1 | |
| dc.identifier.startpage | 34 | |
| dc.identifier.endpage | 44 | |
| dc.contributor.firstauthorID | 219441 | |
